NRX Pharmaceuticals, Inc. (NRXP) Reports Material Event to SEC
NRX Pharmaceuticals, Inc. (NASDAQ:NRXP) filed a Form 8-K with the Securities and Exchange Commission on January 16, 2026, disclosing a material event. NRX Pharmaceuticals, Inc.'s…
Read more
